7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 
      
    		                
      operating activities:
    		                
      net income
    		3,998,000 -4,649,000 1,340,000 9,754,000 -13,985,000 4,828,000 9,334,000 64,261,000 79,276,000 -152,466,000 -116,354,000 -4,381,000 -15,602,000 -30,506,000 -3,186,000 -66,332,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                
      depreciation and amortization
    		3,271,000 3,504,000 3,296,000 3,567,000 3,911,000 3,873,000 2,193,000 4,839,000 4,203,000 4,273,000 4,198,000 4,747,000 5,091,000 5,643,000 5,727,000 6,179,000 
      non-cash operating lease costs
    		2,741,000 3,124,000 3,980,000 3,615,000 3,592,000 3,433,000 3,902,000 3,525,000 3,776,000 3,674,000 5,350,000 3,427,000 4,124,000 4,140,000 4,577,000 3,344,000 
      stock-based compensation
    		69,608,000 70,392,000 60,178,000 61,688,000 66,000,000 65,499,000 64,101,000 56,041,000 56,508,000 55,208,000 50,342,000 37,874,000 34,155,000 34,558,000 29,275,000 35,099,000 
      deferred income taxes
    		-3,795,000 1,806,000 -3,041,000 -17,770,000 1,743,000 -745,000 -831,000 -3,365,000 358,000 -7,479,000 11,477,000 -793,000 -27,439,000 -51,202,000 -6,145,000 17,009,000 
      amortization of intangible assets and acquired technology
    		25,679,000 25,548,000 25,322,000 29,435,000 30,792,000 32,745,000 32,773,000 37,384,000 37,494,000 37,237,000 37,165,000 46,698,000 46,934,000 47,395,000 47,798,000 60,964,000 
      amortization of debt issuance costs
    		998,000 976,000 956,000 956,000 933,000 903,000 887,000 883,000 870,000 857,000 847,000 872,000 898,000 918,000 919,000 1,114,000 
      amortization of investment discount, net of premium
    		-798,000 -561,000 -753,000 -982,000 -1,222,000 -1,408,000 -1,440,000 -1,446,000 -1,225,000 -900,000 -851,000 -722,000     
      debt refinancing costs
    		   0 0            
      changes in operating assets and liabilities:
    		                
      accounts receivable
    		4,971,000 -46,763,000 232,538,000 -238,027,000 42,149,000 -44,290,000 220,708,000 -220,851,000 23,303,000 -38,332,000 197,579,000 -191,965,000 34,562,000 -37,563,000 177,717,000 -174,080,000 
      prepaid expenses and other assets
    		18,508,000 6,570,000 6,298,000 -1,136,000 276,000 8,430,000 -233,000 -24,003,000 -1,187,000 16,098,000 10,983,000 -35,852,000 6,650,000 8,176,000 -4,485,000 -44,205,000 
      accounts payable and accrued liabilities
    		-1,134,000 24,342,000 -88,361,000 63,972,000 -3,461,000 5,001,000 -97,023,000 87,309,000 -4,740,000 14,749,000 -118,076,000 62,095,000 -2,742,000 16,289,000 -126,339,000 102,188,000 
      income taxes payable
    		42,055,000 -44,824,000 -6,085,000 50,109,000 16,903,000 -31,305,000 -43,507,000 -67,792,000 -96,176,000 106,566,000 22,184,000 -10,464,000 7,728,000 32,844,000 -17,981,000 -22,191,000 
      deferred revenue
    		-17,395,000 -14,889,000 -81,494,000 181,677,000 -41,133,000 -23,478,000 -59,222,000          
      net cash from operating activities
    		148,707,000 24,576,000 154,174,000 146,858,000 106,498,000 24,852,000 131,642,000 101,042,000 58,718,000 36,705,000 69,882,000 60,710,000 53,259,000 15,933,000 70,155,000 86,290,000 
      capex
    		-2,310,000 -1,650,000 -2,426,000 -1,172,000 -681,000 -1,771,000 485,000 -752,000 -1,832,000 -2,384,000 49,000 -3,880,000 405,000 -740,000 140,000 -6,414,000 
      free cash flows
    		146,397,000 22,926,000 151,748,000 145,686,000 105,817,000 23,081,000 132,127,000 100,290,000 56,886,000 34,321,000 69,931,000 56,830,000 53,664,000 15,193,000 70,295,000 79,876,000 
      investing activities:
    		                
      purchases of property and equipment
    		-1,783,000 -1,561,000 -3,147,000 -1,607,000 -772,000 -1,175,000 -390,000 -1,624,000 -1,804,000 -1,891,000 -1,224,000 -3,892,000 -573,000 -356,000 -644,000 -4,802,000 
      purchases of investments
    		-26,813,000 -58,693,000 -175,692,000 -129,943,000 -124,378,000 -122,558,000 -146,997,000 -73,400,000 -107,148,000 -117,628,000 -30,297,000 -108,795,000 -132,577,000 -31,442,000 -17,226,000 -26,243,000 
      maturities of investments
    		183,900,000 104,000,000 172,500,000 104,800,000 148,400,000 52,093,000 149,939,000 72,100,000 28,307,000 71,200,000 80,500,000 41,960,000 20,287,000 23,187,000 24,114,000 20,887,000 
      sales of investments
    		0       0 15,712,000        
      other
    		   0 0 0 1,878,000          
      net cash from / (used in) investing activities
    		155,304,000                
      financing activities:
    		                
      payment of debt
    		-4,687,000 -4,688,000 -4,688,000 -4,686,000 -4,688,000 -6,659,000 -4,688,000 -4,688,000 -4,688,000 -4,688,000 -4,688,000 -4,687,000 -4,688,000   -1,355,826,000 
      payment of debt refinancing costs
    		   0 0            
      proceeds from issuance of debt
    		   0 0            
      proceeds from issuance of common stock under employee stock purchase plan
    		8,613,000 0 14,579,000 0 11,470,000 0 13,797,000 0 12,098,000 0 16,131,000 0 19,146,000 0 13,644,000  
      payments for dividends related to class b-2 shares
    		0 0 -10,000 0 0 0 -12,000 0 0 0 -12,000 0 0 0 -24,000  
      payments for repurchases of common stock
    		0 0 -101,346,000              
      payments for taxes related to net share settlement of equity awards
    		-25,929,000 -19,590,000 -29,015,000 -23,026,000 -22,128,000 -30,848,000 -45,843,000 -18,624,000 -15,152,000       -1,328,000 
      proceeds from issuance of shares under equity plans
    		24,602,000 22,987,000 978,000 9,223,000 5,385,000 28,860,000 28,861,000 37,087,000 12,039,000 4,172,000 3,481,000      
      net cash from financing activities
    		2,599,000 -1,291,000 -119,502,000      4,297,000 -11,616,000 14,912,000      
      effect of foreign exchange rate changes on cash and cash equivalents
    		-9,411,000 21,050,000 15,472,000 -19,878,000 14,321,000 -1,790,000 -5,562,000  -6,302,000 -672,000 1,255,000      
      net increase in cash and cash equivalents
    		297,199,000 96,010,000 43,805,000 -20,113,000 134,108,000 -56,603,000 122,625,000  -20,696,000 -104,000 135,028,000      
      cash and cash equivalents at beginning of period
    		0 0 912,460,000 0 0 0 732,443,000  0 0 497,879,000      
      cash and cash equivalents at end of period
    		297,199,000 96,010,000 956,265,000 -20,113,000 134,108,000 -56,603,000 855,068,000  -20,696,000 -104,000 632,907,000      
      supplemental disclosures:
    		                
      cash paid for interest
    		30,515,000 30,225,000 30,002,000 32,470,000 36,188,000 37,922,000 37,782,000 38,251,000 38,027,000 36,580,000 34,482,000 30,329,000 23,753,000 16,803,000 13,678,000 18,332,000 
      cash paid for income taxes, net of refunds
    		6,829,000 12,128,000 9,740,000 26,049,000 10,745,000 12,970,000 18,873,000 8,232,000 25,224,000 22,979,000 25,907,000 19,979,000 22,492,000 25,148,000 25,311,000 16,057,000 
      non-cash investing and financing activities:
    		                
      purchases of property and equipment recorded in accounts payable and accrued liabilities
    		-527,000 -89,000 721,000 435,000 91,000 -596,000 875,000 872,000 -28,000 -493,000 1,273,000 12,000 978,000 -384,000 784,000 -1,612,000 
      net cash (used in) / provided by investing activities
    		  -6,339,000              
      business acquisitions, net of cash acquired
    		                
      net cash from investing activities
    		   -26,750,000 23,250,000 -71,640,000 4,430,000 -2,924,000   48,979,000 -70,727,000 -112,863,000 -8,611,000 6,244,000 -10,048,000 
      payments of offering costs
    		           0 0 -1,580,000 -505,000  
      net activity from derivatives with an other-than-insignificant financing element
    		           7,087,000 2,283,000 -2,548,000 -4,586,000 -4,816,000 
      net cash (used in)/ provided by financing activities
    		               -39,694,000 
      business acquisition, net of cash acquired
    		                
      net cash (used in) / provided by financing activities
    		      -7,885,000          
      loss on debt refinancing
    		                
      unrealized gain on remeasurement of debt
    		               1,609,000 
      contract liabilities
    		       164,257,000 -43,742,000 -2,780,000 -34,962,000 149,174,000 -40,820,000 -14,759,000 -37,722,000 134,710,000 
      proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and offering costs
    		                
      payments for share repurchases
    		               0 
      payment of debt issuance costs
    		                
      payment of contingent consideration
    		                
      net cash from / (used in) financing activities
    		                
      effect of foreign exchange rate changes on cash, cash equivalents, and restricted cash
    		           3,223,000 -5,538,000 -8,374,000 -2,429,000 2,862,000 
      net increase in cash, cash equivalents, and restricted cash
    		           -1,984,000 -43,338,000 -2,100,000 87,205,000 39,410,000 
      cash, cash equivalents, and restricted cash at beginning of period
    		           0 0 0 458,096,000 0 
      cash, cash equivalents, and restricted cash at end of period
    		           -1,984,000 -43,338,000 -2,100,000 545,301,000 39,410,000 
      deferred offering costs payable or accrued but not paid
    		              1,580,000  
      payment for settlement of vested stock options
    		                
      proceeds from issuance of shares upon exercise of options
    		                
      gain on sale of investment in equity interest
    		               0 
      payment of deferred and contingent consideration
    		                
      proceeds from issuance of shares
    		            5,063,000 7,768,000 4,706,000  
      net cash provided/ (used in) by financing activities
    		            21,804,000 -1,048,000 13,235,000  
      sale of investments in equity interest
    		                
      purchase of equity method investment
    		                
      sale of investment in equity interest
    		                
      proceeds from issuance of shares upon exercise of vested options
    		                
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.